The ability of fermented BCP to modify the cellular redox status [production of reactive oxygen species (ROS)], to modulate the secretion of pro-inflammatory mediators [interleukin-8 (IL-8), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1), tumor necrosis factors-α (TNF-α), and prostaglandin E2 (PGE-2)], and to counteract the disruption of epithelial integrity was investigated through a model of intestinal absorption using the human colon adenocarcinoma cell line-2 (Caco-2). The gene discussed is CCL2; the disease is colon adenocarcinoma.